Patent · US Active

Aminosteroids for the treatment of a PTP1B associated disease

US10556923B2 · kind B2 · utility

0Cited by

5References

8Claims

0Family size

Assignee

Ohr Pharmaceutical Inc. · US

Inventors

Michael McLane · Lansdale, US
Inez Ruiz-White · Mount Laurel, US
W. Lee Maloy · Lansdale, US
Henry Wolfe · Lower Burrell, US

Key dates

Filing date	Mar 12, 2019
Grant date	Feb 11, 2020
Priority date	—
Expiry date	Mar 12, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J43/003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.